← Back to Search

Ureteroscopy (URS) (standard treatment) for Kidney Stones (ENORC Trial)

N/A
Waitlist Available
Led By Naeem Bhojani, MD
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

ENORC Trial Summary

This trial will test if removing non-obstructing kidney stones can reduce pain or improve quality of life for people with renal stone disease.

Eligible Conditions
  • Kidney Stones

ENORC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluation of pain

ENORC Trial Design

1Treatment groups
Experimental Treatment
Group I: Ureteroscopy (URS) (standard treatment)Experimental Treatment1 Intervention
Endoscopic procedure used to remove kidney stones
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ureteroscopy
2016
N/A
~1430

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterOTHER
494 Previous Clinical Trials
2,798,799 Total Patients Enrolled
University of California, Los AngelesOTHER
1,529 Previous Clinical Trials
10,277,808 Total Patients Enrolled
Henry Ford Health SystemOTHER
300 Previous Clinical Trials
2,099,956 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are actively engaged in this research initiative?

"Affirmative. Clinicaltrials.gov hosts information which demonstrates that enrollment is still open for this research project, initially posted on August 28th 2018 and revised last on July 26th 2022. Nine different medical sites are currently looking to recruit 53 participants."

Answered by AI

Are there any slots available for participation in this study?

"Confirmed. Data on clinicaltrials.gov indicates that this medical research is still recruiting participants, which began in August 2018 and was most recently updated in July 2022. The trial requires 53 patients to be enrolled from 9 distinct sites."

Answered by AI

Are there numerous sites operating the trial within this metropolitan area?

"Nine clinical centres are participating in this medical trial, with Baylor Scott and White Health located in Temple, Centre Hospitalier de l'université de Montréal (CHUM) based out of Montreal, and Indiana University situated in Bloomington. Additionally, there are 6 other sites looking for participants."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
~7 spots leftby Apr 2025